Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Examining immune-inflammatory mechanisms of probiotic supplementation in depression: secondary findings from a randomized clinical trial.
Sempach L, Doll JPK, Limbach V, Marzetta F, Schaub AC, Schneider E, Kettelhack C, Mählmann L, Schweinfurth-Keck N, Ibberson M, Lang UE, Schmidt A. Sempach L, et al. Among authors: kettelhack c. Transl Psychiatry. 2024 Jul 24;14(1):305. doi: 10.1038/s41398-024-03030-7. Transl Psychiatry. 2024. PMID: 39048549 Free PMC article. Clinical Trial.
Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial.
Schaub AC, Schneider E, Vazquez-Castellanos JF, Schweinfurth N, Kettelhack C, Doll JPK, Yamanbaeva G, Mählmann L, Brand S, Beglinger C, Borgwardt S, Raes J, Schmidt A, Lang UE. Schaub AC, et al. Among authors: kettelhack c. Transl Psychiatry. 2022 Jun 3;12(1):227. doi: 10.1038/s41398-022-01977-z. Transl Psychiatry. 2022. PMID: 35654766 Free PMC article. Clinical Trial.
Effects of a probiotic add-on treatment on fronto-limbic brain structure, function, and perfusion in depression: Secondary neuroimaging findings of a randomized controlled trial.
Yamanbaeva G, Schaub AC, Schneider E, Schweinfurth N, Kettelhack C, Doll JPK, Mählmann L, Brand S, Beglinger C, Borgwardt S, Lang UE, Schmidt A. Yamanbaeva G, et al. Among authors: kettelhack c. J Affect Disord. 2023 Mar 1;324:529-538. doi: 10.1016/j.jad.2022.12.142. Epub 2023 Jan 4. J Affect Disord. 2023. PMID: 36610592 Free article. Clinical Trial.
Effect of short-term, high-dose probiotic supplementation on cognition, related brain functions and BDNF in patients with depression: a secondary analysis of a randomized controlled trial.
Schneider E, Doll JPK, Schweinfurth N, Kettelhack C, Schaub AC, Yamanbaeva G, Varghese N, Mählmann L, Brand S, Eckert A, Borgwardt S, Lang UE, Schmidt A. Schneider E, et al. Among authors: kettelhack c. J Psychiatry Neurosci. 2023 Jan 18;48(1):E23-E33. doi: 10.1503/jpn.220117. Print 2023 Jan-Feb. J Psychiatry Neurosci. 2023. PMID: 36653035 Free PMC article. Clinical Trial.
Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression-Case Report.
Doll JPK, Vázquez-Castellanos JF, Schaub AC, Schweinfurth N, Kettelhack C, Schneider E, Yamanbaeva G, Mählmann L, Brand S, Beglinger C, Borgwardt S, Raes J, Schmidt A, Lang UE. Doll JPK, et al. Among authors: kettelhack c. Front Psychiatry. 2022 Feb 17;13:815422. doi: 10.3389/fpsyt.2022.815422. eCollection 2022. Front Psychiatry. 2022. PMID: 35250668 Free PMC article.
Development of a Clinical Prediction Model for Anastomotic Leakage in Colorectal Surgery.
Ochs V, Taha-Mehlitz S, Lavanchy JL, Steinemann D, Müller BP, Rosenberg R, Flaifel M, Enodien B, Frey DM, Baltuonis M, Vorburger S, Flemming S, Kollmann L, Lock JF, Staartjes VE, Grass JK, Melling N, Rousek M, Degutyte AE, Abeciunas V, Poskus T, Ponholzer F, Öfner D, El-Hussuna A, Bardakcioglu O, Neumann K, Spence RT, Sutton T, Honaker MD, Cattin PC, Taha A; 2015 European Society of Coloproctology Collaborating Group. Ochs V, et al. JAMA Netw Open. 2025 Oct 1;8(10):e2538267. doi: 10.1001/jamanetworkopen.2025.38267. JAMA Netw Open. 2025. PMID: 41114976 Free PMC article.
Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma.
König D, Kasenda B, Sandholzer M, Chirindel A, Zingg A, Ritschard R, Thut H, Glatz K, Kappos EA, Schaefer D, Kettelhack C, Passweg J, Baur K, Holbro A, Buser A, Lardinois D, Jeker LT, Khanna N, Stenner F, Matter MS, Rodrigues Mantuano N, Binder M, Zippelius A, Läubli H. König D, et al. Among authors: kettelhack c. Immunooncol Technol. 2024 Aug 22;24:100728. doi: 10.1016/j.iotech.2024.100728. eCollection 2024 Dec. Immunooncol Technol. 2024. PMID: 39801681 Free PMC article.
101 results